Diagnosis of HIV-1 infection in children younger than 18 months in the United States

Pediatrics

Volumn 120, Issue 6, 2007, Pages

  Read, Jennifer S ^c   Havens, Peter ^c   Emmanuel, Patricia ^c   Flynn, Patricia ^c   Henry Reid, Lisa ^c   Hoyt, Laura ^c   Van Dyke, Russell ^c   Dominguez, Kenneth ^a   Mofenson, Lynne ^b   Brady, Michael ^c   Emanuel, Anjie ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NONE

Author keywords

Children; Diagnosis; HIV 1; Infants; United States

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEVIRAPINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BREAST FEEDING; CIRCULATION; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOFLUORESCENCE; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MATERNAL DISEASE; MOTHER; PEDIATRICS; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; UNITED STATES; VERTICAL TRANSMISSION; VIROLOGY; VIRUS CULTURE;

HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; UNITED STATES;

EID: 36849071893     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-2951     Document Type: Article

References (127)

1. Read JS. Prevention of mother-to-child transmission of HIV. In: Zeichner SL, Read JS, eds. Textbook of Pediatric HIV Care. Cambridge, England: Cambridge University Press; 2005
2. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709-712
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180
4. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Women and Infants' Transmission Study Group. J Acquir Immune Defic Syndr. 2002;29:484-494
5. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773-780
6. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire : a randomised trial. Lancet. 1999;353:781-785
7. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebocontrolled multicentre trial. DITRAME Study Group. Lancet. 1999;353:786-792
8. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000;343:982-991
9. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-868
10. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomized, doubleblind, placebo-controlled trial. Lancet. 2002;359:1178-1186
11. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. South African Intrapartum Nevirapine Trial (SAINT) Investigators. J Infect Dis. 2003;187:725-735
12. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353:1035-1039
13. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174
14. Lindegren ML, Byers RH Jr, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282:531-538
15. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005, volume 17. Available at: www.cdc.gov/hiv/topics/surveillance/resources/ reports/2005report/default.htm. Accessed October 29, 2007
16. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2004. Available at: www.cdc.gov/hiv/topics/ surveillance/resources/reports/2004report/default.htm. Accessed October 29, 2007
17. World Health Organization. Acquired immunodeficiency syndrome (AIDS) WHO/CDC case definition for surveillance. Wkly Epidemiol Rec. 1986;61:69-73
18. World Health Organization. AIDS: 1987 revision of CDC/WHO case definition. Bull World Health Organ. 1988;66:259-263, 269-273
19. World Health Organization. Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec. 1990;65:221-224
20. World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents. Wkly Epidemiol Rec. 1994;69:273-275
21. World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach. 2003 Revision. Geneva, Switzerland: World Health Organization; 2004. Available at: www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf. Accessed October 29, 2007
22. World Health Organization, Division of Diarrhoeal and Acute Respiratory Disease Control. Integrated management of the sick child. Bull World Health Organ. 1995;73:735-740
23. Lepage P, van der Perre P, Dabis F, et al. Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. AIDS. 1989;3:221-225
24. Horwood C, Liebeschuetz S, Blaauw D, Cassol S, Qazi S. Diagnosis of paediatric HIV infection in a primary health care setting with a clinical algorithm. Bull World Health Organ. 2003;81:858-866
25. Jones SA, Sherman GG, Coovadia AH. Can clinical algorithms deliver an accurate diagnosis of HIV infection in infancy? Bull World Health Organ. 2005;83:559-560
26. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: World Health Organization; 2006. Available at: www.who.int/hiv/pub/guidelines/hivstaging/en. Accessed October 29, 2007
27. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists, AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 1987;36(suppl 1):1S-15S
28. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep. 1987;36:225-230, 235-236
29. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19
30. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep. 1994;43(RR-12):1-10
31. Connick E. Incomplete antibody evolution and seroreversion after treatment of primary HIV type 1 infection: what is the clinical significance? Clin Infect Dis. 2005;40:874-875
32. Hoffman C, Rockstroh JK, Kamps BS, eds. HIV Medicine 2006. Paris, France: Flying Publisher; 2006. Available at: www.HIVMedicine.com. Accessed: October 6, 2006
33. Constantine NT, Callahan JD, Watts DM. Retroviral Testing: Essentials for Quality Control and Laboratory Diagnosis. Boca Raton, FL: CRC Press; 1992
34. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep. 2006;8:125-131
35. Centers for Disease Control and Prevention. Notice to readers: protocols for confirmation of reactive HIV tests. MMWR Morb Mortal Wkly Rep. 2004;53(10):221-222
36. Sirinavin S, Atamasirikul K. Semiquantitative human immunodeficiency virus antibody tests in diagnosis of vertical infection. Pediatr Infect Dis J. 2000;19:1153-1157
37. Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 7):1-7
38. Shearer WT, Easley KA, Goldfarb J, et al. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol. 2000;106:559-566
39. Rouet F, Inwoley A, Ekouevi DK, et al. CD4 percentages and total lymphocyte counts as early surrogate markers for pediatrics HIV-1 infection in resource-limited settings. ANRS 1201/1202 Ditrame Plus Study Group. J Trop Pediatr. 2006;52:346-354
40. Zijenah LS, Katzenstein DA, Nathoo KJ, et al. T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years. J Transl Med. 2005;3:6
41. Read JS, Pahwa S, Yin W, et al. CD4/CD8 ratio for diagnosis of HIV-1 infection in infants: the Women and Infants Transmission Study. Presented at The 14th Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007; Los Angeles, California. Abstract 686
42. Swaminathan S, Gangadevi P, Perumal V, et al. CD4/CD8 ratio as a surrogate marker for HIV infection in infancy. Presented at The 14th Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007; Los Angeles, California. Abstract 685
43. Shearer WT, Pahwa S, Read JS, et al. CD4/CD8 T-cell ratio predicts HIV infection in infants: the National Heart, Lung, and Blood Institute P(2)C(2) study. J Allergy Clin Immunol. 2007;123:S46
44. Lambert JS, Moye J Jr, Plaeger SF, et al. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol. 2005;12:622-631
45. Peterlin BM, Luciw PA. Replication of the human immunodeficiency virus: strategies for inhibition. Biotechnology. 1988;6:794-799
46. Hollinger FB, Bremer JW, Myers LE, Gold JW, McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Labs. J Clin Microbiol. 1992;30:1787-1794
47. Krivine A, Yakudima A, Le May M, Pena-Cruz V, Huang AS, McIntosh K. A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr. 1990;116:372-376
48. De Rossi A, Ades AE, Mammano F, Del Mistro A, Amadori A, Giaquinto C, Chieco-Bianchi L. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS. 1991;5:15-20
49. Burgard M, Mayaux MJ, Blanche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med. 1992;327:1192-1197
50. Borkowsky W, Krasinski K, Pollack H, Hoover W, Kaul A, Ilmet-Moore T. Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J Infect Dis. 1992;166:616-619
51. Kline MW, Lewis DE, Hollinger FB, et al. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1994;13:90-94
52. Lambert JS, Harris DR, Stiehm ER, et al. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr. 2003;34:512-519
53. Rogers MF, Ou CY, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med. 1989;320:1649-1654
54. Sninsky JJ, Kwok S. Detection of human immunodeficiency viruses by the polymerase chain reaction. Arch Pathol Lab Med. 1990;114:259-262
55. Kovacs A, Xu J, Rasheed S, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J. 1995;14:948-954
56. Bremer JW, Lew JF, Cooper E, et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr. 1996;129:198-207
57. Kuhn L, Abrams EJ, Chinchilla M, Tsai WY, Thea DM. Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS. 1996;10:1181-1182
58. Nelson RP Jr, Price LJ, Halsey AB, et al. Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification. Arch Pediatr Adolesc Med. 1996;150:40-45
59. Cunningham CK, Charbonneau TT, Song K, et al. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J. 1999;18:30-35
60. Puthanakit T, Apichartpiyakul C, Sirisanthana V. An in-house HIV DNA PCR assay for early diagnosis of HIV infection in children in Thailand. J Med Assoc Thai. 2003;86:758-765
61. Sherman GG, Cooper PA, Coovadia AH, et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993-997
62. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005;38:615-617
63. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9:F7-F11
64. Owens DK, Holodniy M, McDonald TW, Scott J, Sonnad S. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants [published correction appears in JAMA. 1996;276:1302]. JAMA. 1996;275:1342-1348
65. Delamare C, Burgard M, Mayaux MJ, et al. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:121-125
66. Steketee RW, Abrams EJ, Thea DM, et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis. 1997;175:707-711
67. Simonds RJ, Brown TM, Thea DM, et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. AIDS. 1998;12:1545-1549
68. Young NL, Shaffer N, Chaowanachan T, et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Acquir Immune Defic Syndr. 2000;24:401-407
69. Souza IE, Azevedo ML, Succi RC, Machado DM, Diaz RS. RNA viral load test for early diagnosis of vertical transmission of HIV-1 infection. J Acquir Immune Defic Syndr. 2000;23:358-360
70. Reisler RB, Thea DM, Pliner V, et al. Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: a comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction. Perinatal AIDS Collaborative Transmission Studies (PACTS) Members. J Acquir Immune Defic Syndr. 2001;26:93-102
71. Rouet F, Montcho C, Rouzioux C, et al. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay. Abidjan DITRAME Study Group (ANRS 049 clinical trial). AIDS. 2001;15:1849-1856
72. Nesheim S, Palumbo P, Sullivan K, et al. Quantitative RNA testing for diagnosis of HIV-infected infants. J Acquir Immune Defic Syndr. 2003;32:192-195
73. Rouet F, Sakarovitch C, Msellati P, et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Abidjan ANRS 049 Ditrame Study Group. Pediatrics. 2003;112(4). Available at: www.pediatrics.org/cgi/ content/full/112/4/e289. Accessed May 16, 2007
74. Braun J, Plantier JC, Hellot MF, et al. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS. 2003;17:331-336
75. Rouet F, Ekouevi DK, Chaix ML, et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005;43:2709-2717
76. Miles SA, Balden E, Magpantay L, et al. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med. 1993;328:297-302
77. Schüpbach J, Boni J, Tomasik Z, Jendis J, Seger R, Kind C. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis. 1994;170:318-324
78. Nielsen K, Santos E, Rubini N, et al. Immune complex-dissociated p24 antigenemia in the diagnosis of human immunodeficiency virus infection in vertically infected Brazilian children. Pediatr Infect Dis J. 1995;14:67-69
79. Lewis DE, Adu-Oppong A, Hollinger FB, et al. Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants. Clin Diagn Lab Immunol. 1995;2:87-90
80. Bulterys M, Farzadegan H, Chao A, et al. Diagnostic utility of immune-complex-dissociated p24 antigen detection in perinatally acquired HIV-1 infection in Rwanda. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:186-191
81. Lyamuya E, Bredberg-Raden U, Massawe A, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of motherto-infant transmission of HIV-1 in Dares Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:421-426
82. Paul MO, Toedter G, Hofheinz D, et al. Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay. Clin Diagn Lab Immunol. 1997;4:75-78
83. Rich KC, Janda W, Kalish LA, et al. Immune complex-dissociated p24 antigen in congenital or perinatal HIV infection: role in the diagnosis and assessment of risk of infection in infants. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:198-203
84. Panakitsuwan S, Yoshihara N, Hashimoto N, Miyamura K, Chotpitayasunondh T. Early diagnosis of vertical HIV infection in infants by rapid detection of immune complexdissociated HIV p24 antigen. AIDS Patient Care STDS. 1997;11:429-433
85. Nadal D, Boni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis. 1999;180:1089-1095
86. Guay LA, Hom DL, Kabengera SR, et al. HIV-1 ICD p24 antigen detection in Ugandan infants: use in early diagnosis of infection and as a marker of disease progression. J Med Virol. 2000;62:426-434
87. Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P. p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol. 2003;41:1016-1022
88. Ribas SG, Ondoa P, Schüpbach J, van der Groen G, Fransen K. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency virus type 1 seropositive individuals. J Virol Methods. 2003;113:29-34
89. Sherman GG, Stevens G, Stevens WS. Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection. Pediatr Infect Dis J. 2004;23:173-176
90. De Baets AJ, Edidi BS, Kasali MJ, et al. Pediatric human immunodeficiency virus screening in an African district hospital. Clin Diagn Lab Immunol. 2005;12:86-92
91. Zijenah LS, Tobaiwa O, Rusakaniko S, et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr. 2005;39:391-394
92. Respess RA, Cachafeiro A, Withum D, et al. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol. 2005;43:506-508
93. Patton JC, Sherman GG, Coovadia AH, Stevens WS, Meyers TM. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol. 2006;13:152-155
94. Schüpbach J. Measurement of HIV-1 p24 antigen by signalamplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev. 2002;4:83-92
95. Rakusan TA, Parrott RH, Sever JL. Limitations in the laboratory diagnosis of vertically acquired HIV infection. J Acquir Immune Defic Syndr. 1991;4:116-121
96. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet. 1991;337:253-260
97. Moodley D, Bobat RA, Coutsoudis A, Coovadia HM. Predicting perinatal human immunodeficiency virus infection by antibody patterns. Pediatr Infect Dis J. 1995;14:850-852
98. Moodley D, Coovadia HM, Bobat RA, Madurai S, Sullivan JL. The relationship between maternal-infant antibody levels and vertical transmission of HIV-1 infection. J Trop Pediatr. 1997;43:75-79
99. Sherman GG, Stevens WS, Stevens G, Galpin JS. Diagnosis of human immunodeficiency virus infection in perinatally exposed orphaned infants in a resource-poor setting. Pediatr Infect Dis J. 2000;19:1014-1015
100. Andiman WA, Simpson BJ, Olson B, Dember L, Silva TJ, Miller G. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection: results of a prospective cohort study. Am J Dis Child. 1990;144:758-766
101. Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hillyer GV, Diaz C. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J. 1995;14:382-387
102. Palasanthiran P, Robertson P, Ziegler JB, Graham GG. Decay of transplacental human immunodeficiency virus type 1 antibodies in neonates and infants. J Infect Dis. 1994;170:1593-1596
103. Bryson Y, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992;327:1246-1247
104. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: http://aidsinfo.nih.gov/contentfiles/ PediatricGuidelines.pdf. Accessed October 29, 2007
105. Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep. 1999;48(RR-13):1-27, 29-31
106. Centers for Disease Control and Prevention. 2007 revision of the surveillance case definition for human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) and HIV infection classification system for adults and adolescents, the 2007 revision of the surveillance case definition for HIV infection among children aged <18 months, and the 2007 revision of the surveillance case definition for HIV infection and AIDS among children aged >18 months but <13 years. MMWR Recomm Rep. 2008; in press
107. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labor: a multicenter study. Mother-Infant Rapid Intervention at Delivery (MIRIAD) Study Group. JAMA. 2004;292:219-223
108. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17
109. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus [letter]. N Engl J Med. 1999;340:1042-1043
110. Désiré N, Dehee A, Schneider V, et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol. 2001;39:1303-1310
111. Dunn DT, Simonds RJ, Bulterys M, et al. Interventions to prevent vertical transmission of HIV-1: effect on viral rate in early infant samples. AIDS. 2000;14:1421-1428
112. Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Antivir Ther. 2004;9:179-185
113. McCutchan FE. Global epidemiology of HIV. J Med Virol. 2006;78(suppl 1):S7-S12
114. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science. 2000;288:55-56
115. Karchava M, Pulver W, Smith L, et al. Prevalence of drugresistance mutations and non-subtype B strains among HIV-infected infants from New York State. J Acquir Immune Defic Syndr. 2006;42:614-619
116. Haas J, Geiss M, Bohler T. False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus (HIV) type 1 in children infected with HIV strains of African origin. J Infect Dis. 1996;174:244-245
117. Kline NE, Schwarzwald H, Kline MW. False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 2002;21:885-886
118. O'Shea S, Mullen J, Tong CY. Pediatric diagnosis of human immunodeficiency virus type 1 infection: the problem of false negative DNA polymerase chain reaction results. Pediatr Infect Dis J. 2003;22:476-477
119. Obaro SK, Losikoff P, Harwell J, Pugatch D. Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A/G. Pediatr Infect Dis J. 2005;24:183-184
120. Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the Amplicor HIV-1 monitor test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol. 1999;37:110-116
121. Michael NL, Herman SA, Kwok S, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved Amplicor HIV-1 monitor test with isolates of diverse subtypes. J Clin Microbiol. 1999;37:2557-2563
122. Gueudin M, Lemee V, Ferre V, et al. Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 Group O. J Acquir Immune Defic Syndr. 2004;36:639-641
123. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987;326:662-669
124. Berry N, Ariyoshi K, Balfe P, Tedder R, Whittle H. Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat U3 region in vivo allows subtyping of the principal HIV-2 viral subtypes A and B. AIDS Res Hum Retroviruses. 2001;17:263-267
125. O'Donovan D, Airyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in the Gambia. MRC/Gambia Government/University College London Medical School Working Group on Mother-Child Transmission of HIV. AIDS. 2000;14:441-448
126. Damond F, Descamps D, Farfara I, et al. Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol. 2001;39:4264-4268
127. Schutten M, van den Hoogen B, van der Ende ME, Gruters RA, Osterhaus AD, Niesters HG. Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma. J Virol Methods. 2000;88:81-87